Brigatinib
Brigatinib Brand Name– Alunbrig What is Brigatinib Brigatinib is a tyrosine kinase inhibitor targeting multiple kinases, including anaplastic lymphoma kinase (ALK), ROS1, insulin-like growth factor-1 receptor (IGF-1R), and FLT-3, as well as EGFR deletion and point mutations. It is FDA approved for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung …
